American Oncology Network (AON): Company Research Report
Company Overview
- Name: American Oncology Network (AON)
- Mission: Enabling local access to exceptional oncology care by ensuring the long-term success of community oncology practices, improving quality of care, and enhancing the lives of both patients and medical practitioners.
- Founded: Launched in 2018
- Founders: Specific founders not mentioned; launched by an alliance of physicians and seasoned healthcare leaders.
- Key People:
- Todd Schonherz, Chief Executive Officer
- Stephen “Fred” Divers, MD, Chief Medical Officer and Board Member
- David Afshar, Chief Financial and Operating Officer
- Anthony Belott, Chief Development Officer
- James Gilmore, Chief Pharmacy and Clinical Services Officer
- Kristin Matisziw, Chief Compliance and Risk Officer
- Alti Rahman, Chief Strategy and Innovation Officer
- Ryan Olson, MD, Medical Director of Pathology
- Other board members and executives include a wide range of medical and operational professionals.
- Headquarters: 14543 Global Parkway, Suite 110, Fort Myers, FL 33913
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: AON is recognized as a rapidly expanding network focused on ensuring community-based oncology remains viable, accessible, and effective. It provides comprehensive support including management expertise, ancillary services, and a robust value-based care model.
Products and Services
- Products and Services Offered:
- Specialty Pharmacy: Offers centralized services to streamline operations and reduce drug waste, ensuring patients receive necessary medications efficiently.
- Pathology Services: Provides integrated diagnostic and pathology services to improve patient care outcomes.
- Radiation and Radiology Services: Expands access to radiation oncology care through new clinic openings and advanced technology.
- Care Coordination: Enhances patient outcomes by embedding a comprehensive care management team within practices.
- Value-Based Care Initiatives: Participates in programs such as the Enhancing Oncology Model to provide value-based cancer care.
- High-Level Description: The company offers deeply integrated and comprehensive support to oncology practices, including management expertise, centralized clinical and administrative services, and innovative care models to enhance patient experiences and outcomes.
- Key Features:
- Fully integrated electronic medical records
- Advanced clinical lab facilities
- Participation in community and clinical research
- Innovative care delivery models including value-based frameworks
Recent Developments
- New Products/Services:
- AON has expanded its services in radiation oncology with new clinics.
- Introduction of advanced A.I. software in karyogram segmentation to increase speed to results in the Central Lab.
- New Features:
- Enhanced service lines with new pathology and oral oncolytic pharmacy offerings.
- New Partnerships:
- Partnership with Vantage Health Technologies to enhance cancer care using AI-enabled platforms (October 29, 2024).
- Multiple affiliations with local practices such as Genesis Cancer and Blood Institute.
- Expansion and Growth:
- AON is expanding its network across states, with new locations announced in areas like Cape Coral, FL, and Hawaii, among others.
- Appointment of new board-certified physicians to strengthen care offerings across practices.
- Infrastructure and Investment:
- Relocation and expansion of several clinics to larger premises to accommodate growing service demand.
- Received strategic growth investment from AEA Growth to augment expansion efforts (April 28, 2023).
- Leadership and Governance:
- Appointment of new executives to lead the company’s strategy in clinical innovation and operations.
- Participation and presentation in leading oncology conferences to further knowledge-sharing and thought leadership within the field.
In conclusion, the American Oncology Network continues to be at the forefront of offering community-based oncology care through its innovative service models and robust partnerships, ensuring that high-quality cancer treatment remains accessible across multiple regions.